Archives of Physical Medicine and Rehabilitation
Volume 87, Issue 10 , Pages 1346-1351 , October 2006

Botulinum Toxin Type A for Poststroke Cricopharyngeal Muscle Dysfunction

  • Deog Young Kim, MD, PhD

      Affiliations

    • Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, South Korea
    • ,
  • Chang-il Park, MD, PhD

      Affiliations

    • Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, South Korea
    • ,
  • Suk Hoon Ohn, MD

      Affiliations

    • Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, South Korea
    • Corresponding Author InformationReprint requests to Suk Hoon Ohn, MD, Rehabilitation Hospital, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun-gu, Seoul, 120-752, South Korea
    • ,
  • Ja Young Moon, MD

      Affiliations

    • Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, South Korea
    • ,
  • Won Hyuk Chang, MD, MS

      Affiliations

    • Department and Research Institute of Rehabilitation Medicine, Yonsei University College of Medicine, Seoul, South Korea
    • ,
  • Seung-woo Park, MD, PhD

      Affiliations

    • Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea.

References 

  1. Horner J, Massey EW, Brazer SR. Aspiration in bilateral stroke patients: a validation study. Neurology. 1993;43:430–433
  2. Veis SL, Logemann JA. Swallowing disorders in persons with cerebrovascular accident. Arch Phys Med Rehabil. 1985;66:372–375
  3. Cruse JP, Edwards DA, Smith JF, Wyllie JH. The pathology of cricopharyngeal dysphagia. Histopathology. 1972;3:223–232
  4. Baredes S, Shah CS, Kaufman R. The frequency of cricopharyngeal dysfunction on videofluoroscopic swallowing studies in patients with dysphagia. Am J Otol. 1997;18:185–189
  5. Ellis FH, Crozier RE. Cervical esophageal dysphagia: indications for and results of cricopharyngeal myotomy. Ann Surg. 1981;194:279–289
  6. Ross ER, Green R, Auslander MO, Biller HF. Cricopharyngeal myotomy: management of cervical dysphagia. Otolaryngol Head Neck Surg. 1982;90:434–441
  7. Van den Bergh P, Francart J, Mourin S, Kollmann P, Laterre EC. Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin. Muscle Nerve. 1995;18:720–729
  8. Borodic GE, Joseph M, Fay L, Cozzolino D, Ferrante RJ. Botulinum A toxin for the treatment of spasmodic torticollis: dysphagia and regional toxin spread. Head Neck. 1990;12:392–399
  9. Blitzer A, Brin MF, Fahn S, Lovelace RE. Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia). Laryngoscope. 1988;98:193–197
  10. Graham HK, Aoki KR, Autti-Ramo I, et al. Recommendations for the use of botulinum toxin type A in the management of cerebral palsy. Gait Posture. 2000;11:67–79
  11. Schneider I, Thumfart WF, Pototschnig C, Eckel HE. Treatment of dysfunction of the cricopharyngeal muscle with botulinum A toxin: introduction of a new, noninvasive method. Ann Otol Rhinol Laryngol. 1994;103:31–35
  12. Blitzer A, Mitchell FB. Use of botulinum toxin for diagnosis and management of cricopharyngeal achalasia. Otolaryngol Head Neck Surg. 1997;116:328–330
  13. Haapaniemi JJ, Laurikainen EA, Pulkkinen J, Marttila RJ. Botulinum toxin in the treatment of cricopharyngeal dysphagia. Dysphagia. 2001;16:171–175
  14. Ahsan SF, Meleca RJ, Dworkin JP. Botulinum toxin injection of the cricopharyngeus muscle for the treatment of dysphagia. Otolaryngol Head Neck Surg. 2000;122:691–695
  15. Alberty J, Oelerich M, Ludwig K, Hartmann S, Stoll W. Efficacy of botulinum toxin A for treatment of upper esophageal sphincter dysfunction. Laryngoscope. 2000;110:1151–1156
  16. Shaw GY, Searl JP. Botulinum toxin treatment for cricopharyngeal dysfunction. Dysphagia. 2001;16:161–167
  17. Murry T, Wasserman T, Carrau RL, Castillo B. Injection of botulinum toxin A for the treatment of dysfunction of the upper esophageal sphincter. Am J Otolaryngol. 2005;26:157–162
  18. Han TR, Paik NJ, Park JW. Quantifying swallowing function after stroke: a functional dysphagia scale based on videofluoroscopic studies. Arch Phys Med Rehabil. 2001;82:677–682
  19. McConnel FM, Cerenko D, Jackson RT, Guffin TN. Timing of major events of pharyngeal swallowing. Arch Otolaryngol Head Neck Surg. 1988;114:1413–1418
  20. Sonies BC, Baum BJ. Evaluation of swallowing pathophysiology. Otolaryngol Clin North Am. 1988;21:637–648
  21. Brant CQ, Siqueira ES, Ferrari AP. Botulinum toxin for oropharyngeal dysphagia: case report of flexible endoscope-guided injection. Dis Esophagus. 1999;12:68–73
  22. Kelly JH. Use of manometry in the evaluation of dysphagia. Otolaryngol Head Neck Surg. 1997;116:355–357
  23. Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN. Treatment of achalasia with intrasphincteric injection of botulinum toxin (A pilot trial). Ann Intern Med. 1994;121:590–591
  24. Pasricha PJ, Ravich WJ, Hendrix TR. Intrasphincteric botulinum toxin for the treatment of achalasia. N Engl J Med. 1995;332:774–778
  25. Pasricha PJ, Rai R, Ravich WJ, Hendrix TR, Kalloo AN. Botulinum toxin for achalasia: long term outcome and predictors of response. Gastroenterology. 1996;110:1410–1415
  26. Ferrari AP, Siqueira ES, Brant CQ. Treatment of achalasia in Chagas’ disease with botulinum toxin. N Engl J Med. 1995;332:834–835

 No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.

PII: S0003-9993(06)00724-6

doi: 10.1016/j.apmr.2006.06.018

Archives of Physical Medicine and Rehabilitation
Volume 87, Issue 10 , Pages 1346-1351 , October 2006

Article Tools

* Image Usage & Resolution